Provided by Tiger Trade Technology Pte. Ltd.

HCW Biologics Inc.

2.60
+0.290012.55%
Post-market: 2.600.00000.00%16:04 EDT
Volume:277.65K
Turnover:700.87K
Market Cap:4.77M
PE:-0.10
High:2.89
Open:2.31
Low:2.28
Close:2.31
52wk High:39.96
52wk Low:1.50
Shares:1.84M
Float Shares:1.65M
Volume Ratio:0.77
T/O Rate:16.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-27.1846
EPS(LYR):-63.7804
ROE:-151.36%
ROA:-13.88%
PB:0.64
PE(LYR):-0.04

Loading ...

Apr 30, 2026

Major Issues Report

Form 8-K - Current report
Apr 24, 2026

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 23, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Apr 17, 2026

Major Issues Report

Form 8-K - Current report
Mar 31, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 31, 2026

Major Issues Report

Form 8-K - Current report
Mar 17, 2026

Major Issues Report

Form 8-K - Current report
Mar 02, 2026

Major Issues Report

Form 8-K - Current report
Feb 19, 2026

Major Issues Report

Form 8-K - Current report
Feb 17, 2026

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 13, 2026

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 13, 2026

Major Issues Report

Form 8-K - Current report
Feb 12, 2026

Correspondence

Form CORRESP - Correspondence
Feb 12, 2026

Correspondence

Form CORRESP - Correspondence
Feb 11, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jan 28, 2026

Correspondence

Form CORRESP - Correspondence
Jan 09, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dec 31, 2025

Major Issues Report

Form 8-K - Current report
Nov 20, 2025

Major Issues Report

Form 8-K - Current report
Nov 19, 2025

Major Issues Report

Form 8-K - Current report